Directors' Dealing

RNS Number : 2398M
Ergomed plc
04 January 2019
 

Ergomed Plc

("Ergomed" or the "Company")

 

Director's Dealing

 

Ergomed, a company focused on providing specialised services to the pharmaceutical industry, announces that on 24 December 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, transferred 176,470 ordinary shares of 1 pence each in the Company ("Share(s)") to Andrew Mackie, a former Director of the Company (the "Transfer"). The Transfer took place following an exercise of options over Ergomed shares owned by Dr Miroslav Reljanovic which had been granted on 20 July 2015 at an exercise price of 1 pence per Share.

 

Following the Transfer, Dr Miroslav Reljanovic's holding has reduced to 10,955,767 Shares (representing 24.4 per cent. of the Company's issued share capital).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr Miroslav Reljanovic

2

Reason for the notification

a)

Position/status

Founder and Executive Vice-Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 GB00BN7ZCY67

b)

Nature of the transaction

Transfer of Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.01

176,470



e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

Volume: 176,470 ordinary shares of 1 pence each, exercise price of 1 pence per share

 

f)

Date of the transaction

24 December 2018

g)

Place of the transaction

Outside of a trading venue

 

 

Enquiries:

 

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)




Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)


James Black (Broker)


 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBIMMTMBJMBBL

Companies

Ergomed (ERGO)
UK 100

Latest directors dealings